GEN Exclusives

More »

GEN News Highlights

More »
Jun 22, 2007

Link Technologies to Manufacture and Sell PNA Monomers through Deal with PNA Inventor Group

  • Link Technologies and the PNA Inventor Group entered into a nonexclusive license agreement to allow Link Technologies to manufacture and sell monomers for peptide nucleic acid (PNA) synthesis worldwide under the PNA Inventor Group’s patents.

    Recent estimates predict that PNA synthesis will account for 10% of the global DNA synthesis market by 2010, a market presently worth $800 million and growing at over 10% per year, according to Link.

    Initially, Link says that it will be offering the preferred Fmoc/Bhoc protected PNA monomers. These monomers are compatible with commercial automated oligonucleotide, peptide, or combinatorial synthesizers. The company anticipates that these products will be available next month.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should the CDC Director Resign?

Do you think the CDC chief should resign?